Radical-Implications-Indication-Specific-Pricing_EMC_Whitepaper (1)

Recent Press Releases

• EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate
• EVERSANA and MyHealthTeam Launch Groundbreaking Direct-to-Patient Solution to Accelerate Time to Diagnosis and Treatment  
• EVERSANA Named AI Excellence Award Winner for Third Consecutive Year, Recognized in Company Category for 2024
• EVERSANA CONSULTING Named a Forbes 2024 Top Management Consulting Firm in the United States
• Tonix Pharmaceuticals Selects EVERSANA to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia